BRAZE INC-A (BRZE)
US10576N1028 - Common Stock
Overall BRZE gets a fundamental rating of 5 out of 10. We evaluated BRZE against 278 industry peers in the Software industry. No worries on liquidiy or solvency for BRZE as it has an excellent financial health rating, but there are worries on the profitability. BRZE shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year BRZE was profitable.
BRZE had a positive operating cash flow in the past year.
BRZE had negative earnings in each of the past 5 years.
BRZE had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
BRZE has a worse Return On Assets (-13.64%) than 65.11% of its industry peers.
BRZE has a Return On Equity (-25.07%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.64% | ||
| ROE | -25.07% | ||
| ROIC | N/A |
ROA(3y)-15.71%
ROA(5y)-17.29%
ROE(3y)-25.19%
ROE(5y)-32.07%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 68.64%, BRZE perfoms like the industry average, outperforming 51.44% of the companies in the same industry.
BRZE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BRZE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.56%
GM growth 5YN/A
2. Health
2.1 Basic Checks
BRZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
BRZE has more shares outstanding than it did 1 year ago.
There is no outstanding debt for BRZE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
BRZE has an Altman-Z score of 6.88. This indicates that BRZE is financially healthy and has little risk of bankruptcy at the moment.
BRZE has a Altman-Z score of 6.88. This is in the better half of the industry: BRZE outperforms 71.22% of its industry peers.
There is no outstanding debt for BRZE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.88 |
ROIC/WACCN/A
WACC11.63%
2.3 Liquidity
A Current Ratio of 1.99 indicates that BRZE should not have too much problems paying its short term obligations.
BRZE's Current ratio of 1.99 is fine compared to the rest of the industry. BRZE outperforms 60.43% of its industry peers.
BRZE has a Quick Ratio of 1.99. This is a normal value and indicates that BRZE is financially healthy and should not expect problems in meeting its short term obligations.
BRZE's Quick ratio of 1.99 is fine compared to the rest of the industry. BRZE outperforms 61.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.99 | ||
| Quick Ratio | 1.99 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 105.56% over the past year.
BRZE shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.30%.
The Revenue has been growing by 46.45% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)105.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)28.3%
Revenue growth 3Y46.45%
Revenue growth 5YN/A
Sales Q2Q%22.66%
3.2 Future
Based on estimates for the next years, BRZE will show a very strong growth in Earnings Per Share. The EPS will grow by 61.01% on average per year.
Based on estimates for the next years, BRZE will show a very strong growth in Revenue. The Revenue will grow by 20.21% on average per year.
EPS Next Y143.4%
EPS Next 2Y77.15%
EPS Next 3Y61.01%
EPS Next 5YN/A
Revenue Next Year26.43%
Revenue Next 2Y21.61%
Revenue Next 3Y20.21%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 2168.50, which means the current valuation is very expensive for BRZE.
Compared to the rest of the industry, the Price/Earnings ratio of BRZE is on the same level as its industry peers.
When comparing the Price/Earnings ratio of BRZE to the average of the S&P500 Index (28.77), we can say BRZE is valued expensively.
Based on the Price/Forward Earnings ratio of 146.54, the valuation of BRZE can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRZE indicates a slightly more expensive valuation: BRZE is more expensive than 60.07% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.38, BRZE is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2168.5 | ||
| Fwd PE | 146.54 |
4.2 Price Multiples
BRZE's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5053.97 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRZE does not grow enough to justify the current Price/Earnings ratio.
BRZE's earnings are expected to grow with 61.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)15.12
PEG (5Y)N/A
EPS Next 2Y77.15%
EPS Next 3Y61.01%
5. Dividend
5.1 Amount
No dividends for BRZE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BRAZE INC-A
NASDAQ:BRZE (12/18/2024, 4:06:07 PM)
After market: 42.53 -0.84 (-1.94%)43.37
-1.38 (-3.08%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.49B
Analysts
Price Target
Short Float %
Short Ratio
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2168.5 | ||
| Fwd PE | 146.54 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)15.12
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.64% | ||
| ROE | -25.07% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.64% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.99 | ||
| Quick Ratio | 1.99 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)105.56%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y143.4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)28.3%
Revenue growth 3Y46.45%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y